Utilizing Metformin to Enhance Fracture Callus Development through AMPK-Mediated Metabolic Stimulation
-
By
-
Vasyl Pastukh
-
Jianying Zhang
-
Peter G. Alexander
-
Satyaj Bhargava
-
Arshia Shams
-
Celina Zhao
-
MaCalus V. Hogan
-
James H-C. Wang
-
July 1, 2026
Clinical Scorecard: Utilizing Metformin to Enhance Fracture Callus Development through AMPK-Mediated Metabolic Stimulation
At a Glance
| Category | Detail |
|---|
| Condition | Femoral Shaft Fractures |
| Key Mechanisms | AMPK activation, mitochondrial biogenesis, inflammation suppression |
| Target Population | Young adults and older adults with femoral shaft fractures |
| Care Setting | Orthopedic trauma care |
Key Highlights
- Metformin enhances angiogenesis and osteogenic differentiation.
- AMPK activation is central to Met's cellular effects.
- Metformin may improve skeletal repair under metabolic and inflammatory stress.
- Open fractures have high risks of infection and delayed healing.
- Therapeutic strategies to enhance bone regeneration are urgently needed.
Guideline-Based Recommendations
Diagnosis
- Assessment of fracture type and severity is crucial.
Management
- Intramedullary nailing is the gold-standard fixation method.
Monitoring & Follow-up
- Regular evaluation of healing progress and potential complications.
Risks
- High risks of infection, delayed union, and non-union in open fractures.
Patient & Prescribing Data
Female Sprague-Dawley rats used in preclinical studies.
Metformin may serve as a systemically deliverable adjunct therapy.
Clinical Best Practices
- Utilize standardized open osteotomy models for reproducibility.
- Implement post-surgical antibiotics and analgesics to prevent infection.
Related Resources & Content
